MetaCap

CollPlant Biotechnologies Balance Sheet

NASDAQ: OPHIHealth CareIndustrial SpecialtiesUSD

3.13-0.08 (-2.49%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CollPlant Biotechnologies financial position

At the end of fiscal 2025, CollPlant Biotechnologies reported total assets of $10.8 million, down 42.4% from a year earlier against total liabilities of $4.7 million. Shareholders' equity stood at $6.1 million, or 56.4% of assets. The company held $5.6 million in cash and equivalents.

The current ratio (current assets divided by current liabilities) was 2.53, meaning short-term assets cover obligations due within a year.

Summary generated from market data by MetaCap's automated system. Methodology

CollPlant Biotechnologies balance sheet (annual)

CollPlant Biotechnologies annual balance sheet
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31FY 20212021-12-31FY 20202020-12-31FY 20192019-12-31FY 20182018-12-31FY 20172017-12-31
Cash & Equivalents5.59M11.91M26.67M29.65M13.15M3.33M3.79M5.35M5.28M
Receivables1.00K150.00K—9.00K270.00K830.00K79.00K——
Inventory573.00K440.00K714.00K1.43M1.08M1.26M888.00K814.00K202.00K
Total Current Assets6.75M13.18M28.02M31.66M45.09M5.68M5.04M7.17M6.46M
Property, Plant & Equipment1.46M2.29M2.79M2.97M2.73M2.11M2.33M1.41M1.03M
Intangible Assets73.00K131.00K188.00K245.00K243.00K82.00K———
Total Assets10.79M18.71M34.13M37.77M51.22M10.84M10.75M8.75M8.09M
Accounts Payable610.00K870.00K980.00K1.13M1.03M798.00K833.00K——
Short-Term Debt———321.00K219.00K————
Total Current Liabilities2.67M2.97M3.25M3.10M3.01M3.39M3.46M2.23M1.42M
Long-Term Debt————30.00K11.00K63.00K—2.00M
Total Liabilities4.70M5.25M5.79M5.49M6.10M6.36M6.66M3.33M5.47M
Shareholders' Equity6.08M13.46M28.34M32.28M45.12M4.48M4.09M5.42M5.17M
Retained Earnings-124.84M-113.35M-96.74M-89.72M-72.80M-73.03M-67.26M-56.10M-50.30M
Total Debt———321.00K249.00K11.00K63.00K—2.00M
Net Cash (Debt)5.59M11.91M26.67M29.33M12.90M3.32M3.73M5.35M3.28M
Shares Outstanding12.80M11.45M11.45M11.19M10.77M6.96M5.67M——

This table shows 9 annual periods of CollPlant Biotechnologies's balance sheet, from FY 2025 back to FY 2017, across 17 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow OPHI's reporting calendar. What is a balance sheet?

More financial data